Cochlear's Sales Slowdown Doesn't Worry New Bull -- Market Talk

Dow Jones

14小時前

2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

March 05, 2025 18:41 ET (23:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2517973044"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517973044\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2517973044?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-06 07:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517973044","market":"us","top_or_hot":-1,"title":"Cochlear's Sales Slowdown Doesn't Worry New Bull -- Market Talk","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 18:41 ET (23:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Cochlear's Sales Slowdown Doesn't Worry New Bull -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCochlear's Sales Slowdown Doesn't Worry New Bull -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-03-06 07:41</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 18:41 ET (23:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COH.AU","symbol_name":"COCHLEAR LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517973044","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517973044","pubTimestamp":1741218060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"COH.AU":"COCHLEAR LTD"},"translate_title":"耳蜗销售放缓并不担心新的牛市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COH.AU":0.9},"content_text":"2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 18:41 ET (23:41 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}